Determining Infected Aortic Aneurysm Treatment Using Focused Detection of Helicobacter cinaedi

Jien Saito; Emiko Rimbara; Shingo Inaguma; Chihiro Hasegawa; Shinji Kamiya; Akihiro Mizuno; Yoshiaki Sone; Tatsuhito Ogawa; Yukihide Numata; Satoru Takahashi; Miki Asano

doi:10.3201/eid2807.212505

Determining Infected Aortic Aneurysm Treatment Using Focused Detection of Helicobacter cinaedi

Emerg Infect Dis. 2022 Jul;28(7):1494-1498. doi: 10.3201/eid2807.212505.

Authors

Jien Saito, Emiko Rimbara, Shingo Inaguma, Chihiro Hasegawa, Shinji Kamiya, Akihiro Mizuno, Yoshiaki Sone, Tatsuhito Ogawa, Yukihide Numata, Satoru Takahashi, Miki Asano

Abstract

We detected Helicobacter cinaedi in 4 of 10 patients with infected aortic aneurysms diagnosed using blood or tissue culture in Aichi, Japan, during September 2017-January 2021. Infected aortic aneurysms caused by H. cinaedi had a higher detection rate and better results after treatment than previously reported, without recurrent infection.

Keywords: Helicobacter cinaedi; Japan; antimicrobial treatment; aortic aneurysm; arteriosclerosis; bacteria; infections.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Aortic Aneurysm*
Bacteremia*
Helicobacter Infections* / diagnosis
Helicobacter Infections* / drug therapy
Helicobacter* / genetics
Humans
Japan

Supplementary concepts

Helicobacter cinaedi